Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar1, Natalie S Callander2, Kehinde Adekola3
11Mayo Clinic Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|December 7, 2020
Summary
This review covers managing solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma, focusing on plasma cell neoplasms in bone marrow.
Area of Science:
- Hematology
- Oncology
Background:
- Multiple myeloma is a cancer of plasma cells.
- These cells accumulate in the bone marrow, causing bone destruction and marrow failure.
Purpose of the Study:
- To discuss the management of solitary plasmacytoma.
- To outline the treatment strategies for smoldering multiple myeloma.
- To cover the care of newly diagnosed multiple myeloma patients.
Main Methods:
- Literature review of current management guidelines.
- Synthesis of evidence-based treatment approaches.
Main Results:
- Detailed discussion of diagnostic criteria and staging.
- Exploration of therapeutic options for each clinical scenario.
Conclusions:
- Effective management requires tailored approaches based on disease stage.
- Early intervention and appropriate treatment are crucial for patient outcomes.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.3K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.7K
